Iloprost for sickle cell pain crisis treatment
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests if iloprost, a medicine that helps open blood vessels, can reduce pain from a sickle cell crisis. It's for adults with sickle cell disease who need to be in the hospital for strong pain medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (any type).
- You are 18 years or older.
- You are in the hospital and need IV pain medicine for a sickle cell pain crisis.
- You have been in the hospital for less than 36 hours.
- You are not pregnant or breastfeeding, and use effective birth control if you could become pregnant.
- You do not have conditions like severe heart disease, recent heart attack, or bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving high-flow oxygen can help treat a painful sickle cell “vaso-occlusive crisis” (VOC) and lower the risk of a serious lung complication. You may be eligible if you’re an adult with sickle cell disease experiencing an opioid-requiring pain flare and have higher risk for lung trouble.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial tests whether crizanlizumab can reduce painful sickle cell crises (called vaso-occlusive crises or VOCs) in people with sickle cell disease who have frequent crises. It may be an option for those who still have crises despite current treatments.
This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.
This trial tests whether numbing a specific area (regional anesthesia) can reduce inflammation and pain during a sickle cell pain crisis. It may offer a new way to manage severe pain without strong medications.
This study tests an investigational medicine called osivelotor for people with sickle cell disease (SCD). The goal is to see if it can reduce pain crises and improve overall health. It is for adults and adolescents aged 12 and older.
Hear when a new Vaso-Occlusive Crises trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.